Medical News

RSS

High-risk insurance pools gaining second life in some states

The Wall Street Journal reports on developments related to insurance coverage and high-risk patients, as well as emerging concerns about how insurance costs could impact consumer spending.

18 Nov 2013

Young adults who had childhood cancer more likely to be frail than their peers

Young adults who survived childhood cancer are more likely than their peers to be frail, according to a St. Jude Children's Research Hospital study, which reported the condition is more common among female survivors than women decades older. The research appears in the November 18 online edition of the Journal of Clinical Oncology.

18 Nov 2013

BIDMC pilot study shows promise for age-related cognitive disorders

It's well known that the brains of meditators change, but it's not entirely clear what those changes mean or how the changes might benefit the meditator. A new pilot study led by researchers at Beth Israel Deaconess Medical Center suggests that the brain changes associated with meditation and stress reduction may play an important role in slowing the progression of age-related cognitive disorders like Alzheimer's disease and other dementias.

18 Nov 2013

6MWT does not reflect activity in primary care COPD patients

Researchers have found that functional exercise capacity does not reflect physical activity among chronic obstructive pulmonary disease patients treated in primary care.

18 Nov 2013

Air pollution link to early childhood pneumonia

European research shows that exposure to elevated levels of air pollutants is associated with an increased risk for pneumonia before the age of 3 years, and particularly in the first year of life.

18 Nov 2013

Findings allay prostatectomy eye pressure concerns

A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.

18 Nov 2013

Disturbed sleep linked to falls in elderly

Sleep disturbances are associated with an increased risk for falls in certain older individuals, a population study suggests.

18 Nov 2013

Grave prognosis for heart patients with treatment-resistant hypertension

Patients with coronary artery disease have a particularly high risk for poor outcomes if they have treatment-resistant hypertension, shows an analysis of the Treating to New Targets trial.

18 Nov 2013

Medical–surgical integration ‘boosts neoadjuvant chemotherapy use for bladder cancer’

Research from the USA indicates that a multidisciplinary approach and coordination between medical and surgical oncology services can help optimize the use of neoadjuvant chemotherapy for bladder cancer.

18 Nov 2013

NEC Display Solutions gets FDA clearance for MultiSync MD210C2 medical-grade monitor

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food and Drug Administration 510(k) cleared 21-inch MultiSync MD210C2 medical-grade monitor, built for the displaying and viewing of digital images for diagnosis by trained physicians.

18 Nov 2013

Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vaccine

Generex Biotechnology Corporation today announced that it has reached a pre-specified point in the ongoing Phase II trial of its AE37 breast cancer vaccine to initiate its primary efficacy analysis. The drug is a novel immunotherapeutic cancer vaccine being developed by the Company's wholly-owned subsidiary, Antigen Express, Inc. A previously released positive interim analysis showed a strong trend toward reduced relapse in breast cancer patients receiving the AE37 vaccine.

18 Nov 2013

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational intravenous solution formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for priority review by the U.S. Food and Drug Administration.

18 Nov 2013

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Vitekta (elvitegravir 85 mg and 150 mg) tablets, an integrase inhibitor for the treatment of HIV-1 infection in adults without known mutations associated with resistance to elvitegravir.

18 Nov 2013

Entire structure of health-care delivery needs to be re-engineered to address threat of antibiotic resistance

The entire structure of health-care delivery for effective antibiotics – from research and development, to distribution and rational use – needs to be re-engineered to address the looming global threat of antibiotic resistance, say the authors of a new report, published today [Sunday 17 November] in The Lancet Infectious Diseases, ahead of European Antibiotic Awareness Day, and the US Centers for Disease Control and Prevention (CDC) ‘Get Smart About Antibiotics Week’ on Monday 18 November.

18 Nov 2013

First Edition: November 18, 2013

Today's headlines include reports about the political implications of the healthcare.gov difficulties as well continued coverage of reaction to President Barack Obama's policy cancellation fix.

18 Nov 2013

Researchers solve structure of key protein in Nipah virus

What began as a summer internship project designed for an undergraduate student evolved into a one-year study of one of the deadliest, but little known viruses.

18 Nov 2013

Smart Use receives Primary Supplier status award for provision of NHS inventory management solutions

Smart Use Solutions, the leading provider of inventory management software to the healthcare sector today announced it has been awarded Primary Supplier status for the provision of NHS inventory management solutions.

18 Nov 2013

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

Paragonix Technologies, Inc. today announced that it has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA) for its Paragonix Sherpa Pak Cardiac Transport System(CTS).

18 Nov 2013

American Academy of Ophthalmology unveils comprehensive eye disease and condition patient database

The American Academy of Ophthalmology today unveiled the nation's first comprehensive eye disease and condition patient database. The IRIS Registry (Intelligent Research in Sight) made its debut in a presentation to 25,000 attendees during the opening session of the world's largest ophthalmic conference - the 117th Annual Meeting of the American Academy of Ophthalmology at the Ernest N. Morial Convention Center in New Orleans.

18 Nov 2013

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, today announces the successful Phase II enrollment of approximately ten patients of whom the majority have already been transplanted and received ATIR™. Kiadis Pharma's lead program, ATIR™, is a cell-based product designed to enable stem cell transplantations from partially mismatched (haploidentical) family donors for blood cancer patients who do not have a standard of care stem cell donor available. Topline data from the trial (CR-AIR-007) is expected in the first half of 2014.

18 Nov 2013

Medical News

High-risk insurance pools gaining second life in some states

Young adults who had childhood cancer more likely to be frail than their peers

BIDMC pilot study shows promise for age-related cognitive disorders

6MWT does not reflect activity in primary care COPD patients

Air pollution link to early childhood pneumonia

Findings allay prostatectomy eye pressure concerns

Disturbed sleep linked to falls in elderly

Grave prognosis for heart patients with treatment-resistant hypertension

Medical–surgical integration ‘boosts neoadjuvant chemotherapy use for bladder cancer’

NEC Display Solutions gets FDA clearance for MultiSync MD210C2 medical-grade monitor

Generex Biotechnology provides update on Phase II trial of AE37 breast cancer vaccine

FDA accepts Merck's NOXAFIL IV solution NDA for priority review

Gilead Sciences gets marketing authorization from European Commission for Vitekta tablets

Entire structure of health-care delivery needs to be re-engineered to address threat of antibiotic resistance

First Edition: November 18, 2013

Researchers solve structure of key protein in Nipah virus

Smart Use receives Primary Supplier status award for provision of NHS inventory management solutions

Paragonix files second 510(k) with FDA for Sherpa Pak Cardiac Transport System

American Academy of Ophthalmology unveils comprehensive eye disease and condition patient database

Kiadis reports successful Phase II enrollment for CR-AIR-007 ATIR blood cancer treatment study

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News